Showing results (671-680 of 1,324) with videos related to

Sort By:
Pageof 133
Behavioural Brain Research|September 14, 2017
Correlation between brain circuit segregation and obesitySeh-Huang Chao, Yin-To Liao, Vincent Chin-Hung Chen, et al.
Brain and Behavior|June 21, 2021
Changes in the gut microbiome associated with infliximab in patients with bipolar disorderAadil Bharwani, Jake C Szamosi, Valerie H Taylor, et al.
International Journal of Environmental Research and Public Health|September 15, 2018
Prevalence of Depression among Migrants: A Systematic Review and Meta-AnalysisShea Q Foo, Wilson W Tam, Cyrus S Ho, et al.
Current Medical Research and Opinion|November 21, 2025
Understanding patient, caregiver, and prescriber preferences for an antipsychotic regimen administered once every 2 months for schizophrenia or bipolar I disorder: a qualitative interview study in North AmericaRoger S McIntyre, Murat Yildirim, Stephanie Loomer, et al.
CNS Spectrums|January 17, 2025
Esketamine nasal spray versus quetiapine XR in adults with treatment-resistant depression: a secondary analysis of the ESCAPE-TRD randomized clinical trialRoger S McIntyre, Gregory Mattingly, Yordan Godinov, et al.
Translational Psychiatry|August 20, 2022
Fluoxetine improves bone microarchitecture and mechanical properties in rodents undergoing chronic mild stress - an animal model of depressionRaymond W Lam, Hee-Kit Wong, Ramruttun A Kumarsing, et al.
Journal of Multidisciplinary Healthcare|May 3, 2021
Economic and Humanistic Burden Associated with Depression and Anxiety Among Adults with Non-Communicable Chronic Diseases (NCCDs) in the United StatesEric Armbrecht, Ruchit Shah, Gregory W Poorman, et al.
Journal of Psychiatric Research|March 18, 2022
The effects of psychostimulants on cognitive functions in individuals with attention-deficit hyperactivity disorder: A systematic reviewAndrea Mckenzie, Shakila Meshkat, Leanna M W Lui, et al.
The International Journal of Neuropsychopharmacology|October 13, 2017
Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual PatientOloruntoba J Oluboka, Martin A Katzman, Jeffrey Habert, et al.
The American Journal of Psychiatry|May 4, 2007
Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trialSidney H Kennedy, Jakub Z Konarski, Zindel V Segal, et al.
Pageof 133